
Opinion|Videos|April 4, 2019
Managing Early Relapse in Multiple Myeloma
Author(s)Saad Z. Usmani, MD
Saad Z. Usmani, MD, FACP, chief of Plasma Cell Disorder, director of Clinical Research in Hematologic Malignancies, Levine Cancer Institute, Atrium Health, discusses how to manage early relapse in multiple myeloma.
Advertisement
Saad Z. Usmani, MD, FACP, chief of Plasma Cell Disorder, director of Clinical Research in Hematologic Malignancies, Levine Cancer Institute, Atrium Health, discusses how to manage early relapse in multiple myeloma.
For the most part, there is no cure for myeloma, so patients go through multiple lines of therapy. There are, however, certain high-risk feaures that can be seen at the time of diagnosis that can help identify patients who are at a high risk of relapse.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
2026 ASCO Plenary Delivers Practice-Changing Progress
2
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
3
FDA Grants ODD to LRRC15-Targeting ADC SOT106 for Osteosarcoma
4
FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion
5







































